| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Disease Models, Animal | 16 | 2019 | 1022 | 0.890 |
Why?
|
| Short Bowel Syndrome | 2 | 2010 | 12 | 0.710 |
Why?
|
| Intestinal Mucosa | 2 | 2010 | 71 | 0.690 |
Why?
|
| Animals | 50 | 2019 | 7541 | 0.680 |
Why?
|
| Abdominal Wall | 1 | 2017 | 22 | 0.580 |
Why?
|
| Endometriosis | 1 | 2017 | 99 | 0.540 |
Why?
|
| Macaca mulatta | 1 | 2017 | 305 | 0.530 |
Why?
|
| Lung Neoplasms | 8 | 2012 | 412 | 0.440 |
Why?
|
| Intestines | 2 | 2010 | 61 | 0.420 |
Why?
|
| Mice | 28 | 2019 | 2484 | 0.410 |
Why?
|
| Mammary Neoplasms, Experimental | 2 | 2010 | 29 | 0.400 |
Why?
|
| Antibodies, Viral | 6 | 2016 | 58 | 0.360 |
Why?
|
| Fish Oils | 1 | 2010 | 36 | 0.360 |
Why?
|
| Adaptation, Physiological | 1 | 2010 | 55 | 0.360 |
Why?
|
| Ileocecal Valve | 1 | 2010 | 1 | 0.350 |
Why?
|
| Jejunum | 1 | 2010 | 5 | 0.350 |
Why?
|
| Colon | 1 | 2010 | 51 | 0.340 |
Why?
|
| Flagellin | 4 | 2016 | 17 | 0.320 |
Why?
|
| Adenoma | 2 | 2008 | 35 | 0.320 |
Why?
|
| Prolactin | 1 | 2008 | 10 | 0.320 |
Why?
|
| Biofilms | 4 | 2012 | 24 | 0.300 |
Why?
|
| Haemophilus influenzae | 4 | 2012 | 14 | 0.290 |
Why?
|
| Bacterial Proteins | 4 | 2012 | 90 | 0.270 |
Why?
|
| Adenocarcinoma | 2 | 2008 | 308 | 0.270 |
Why?
|
| Haemophilus Infections | 3 | 2012 | 8 | 0.260 |
Why?
|
| Genes, ras | 5 | 2009 | 26 | 0.250 |
Why?
|
| Cell Transformation, Neoplastic | 3 | 2012 | 57 | 0.250 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2019 | 743 | 0.250 |
Why?
|
| Influenza Vaccines | 2 | 2016 | 78 | 0.240 |
Why?
|
| Intestinal Volvulus | 1 | 2004 | 1 | 0.240 |
Why?
|
| Primate Diseases | 1 | 2004 | 3 | 0.240 |
Why?
|
| Postoperative Complications | 1 | 2010 | 780 | 0.240 |
Why?
|
| Lung | 6 | 2014 | 249 | 0.240 |
Why?
|
| Rats | 7 | 2019 | 1595 | 0.230 |
Why?
|
| Respiratory Tract Infections | 3 | 2014 | 40 | 0.210 |
Why?
|
| Neoplasms, Radiation-Induced | 2 | 2012 | 13 | 0.210 |
Why?
|
| Adjuvants, Immunologic | 2 | 2015 | 55 | 0.200 |
Why?
|
| Doxorubicin | 2 | 2013 | 82 | 0.190 |
Why?
|
| Antibiotics, Antineoplastic | 2 | 2013 | 74 | 0.190 |
Why?
|
| Mammary Glands, Animal | 3 | 2014 | 65 | 0.190 |
Why?
|
| Lipoproteins | 2 | 2013 | 86 | 0.190 |
Why?
|
| Immunoglobulin G | 4 | 2015 | 122 | 0.190 |
Why?
|
| Macaca fascicularis | 5 | 2019 | 434 | 0.180 |
Why?
|
| Nanotubes, Carbon | 2 | 2011 | 23 | 0.180 |
Why?
|
| Anastomosis, Surgical | 2 | 2010 | 58 | 0.180 |
Why?
|
| Pseudomonas aeruginosa | 2 | 2011 | 35 | 0.180 |
Why?
|
| Diarrhea | 2 | 2010 | 60 | 0.180 |
Why?
|
| Anal Canal | 1 | 2019 | 20 | 0.170 |
Why?
|
| Fecal Incontinence | 1 | 2019 | 23 | 0.170 |
Why?
|
| Bordetella bronchiseptica | 2 | 2010 | 3 | 0.170 |
Why?
|
| Host-Pathogen Interactions | 2 | 2017 | 24 | 0.170 |
Why?
|
| Radiopharmaceuticals | 2 | 2019 | 93 | 0.170 |
Why?
|
| Vaccines, Inactivated | 2 | 2016 | 38 | 0.170 |
Why?
|
| Receptor, Melanocortin, Type 1 | 1 | 2019 | 6 | 0.170 |
Why?
|
| Bioprosthesis | 1 | 2019 | 58 | 0.160 |
Why?
|
| Curcumin | 2 | 2009 | 7 | 0.160 |
Why?
|
| Amnion | 1 | 2019 | 37 | 0.160 |
Why?
|
| Male | 14 | 2019 | 19165 | 0.160 |
Why?
|
| Uveal Neoplasms | 1 | 2019 | 25 | 0.160 |
Why?
|
| Orthomyxoviridae Infections | 2 | 2016 | 20 | 0.160 |
Why?
|
| Hydrogels | 1 | 2019 | 121 | 0.160 |
Why?
|
| Lipopolysaccharides | 2 | 2009 | 109 | 0.160 |
Why?
|
| Energy Transfer | 1 | 2018 | 1 | 0.160 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2012 | 918 | 0.150 |
Why?
|
| Microbial Viability | 3 | 2014 | 5 | 0.150 |
Why?
|
| Wound Healing | 1 | 2019 | 185 | 0.150 |
Why?
|
| Female | 17 | 2019 | 19959 | 0.150 |
Why?
|
| Melanoma | 1 | 2019 | 164 | 0.140 |
Why?
|
| Bacteriuria | 1 | 2017 | 4 | 0.140 |
Why?
|
| Copper | 1 | 2017 | 12 | 0.140 |
Why?
|
| Otitis Media | 3 | 2012 | 23 | 0.140 |
Why?
|
| Urinary Tract | 1 | 2017 | 22 | 0.140 |
Why?
|
| Receptors, Opioid | 1 | 2016 | 12 | 0.140 |
Why?
|
| Bordetella pertussis | 2 | 2014 | 7 | 0.140 |
Why?
|
| Chemokines | 1 | 2016 | 35 | 0.140 |
Why?
|
| Neoplasms | 3 | 2016 | 726 | 0.140 |
Why?
|
| Isoflavones | 2 | 2008 | 81 | 0.140 |
Why?
|
| Mutation | 3 | 2008 | 489 | 0.130 |
Why?
|
| Coordination Complexes | 1 | 2016 | 9 | 0.130 |
Why?
|
| Down-Regulation | 1 | 2016 | 142 | 0.130 |
Why?
|
| Mice, Inbred C57BL | 7 | 2014 | 767 | 0.130 |
Why?
|
| Up-Regulation | 1 | 2016 | 189 | 0.130 |
Why?
|
| Imidazoles | 1 | 2016 | 91 | 0.130 |
Why?
|
| Spinal Cord | 1 | 2016 | 130 | 0.130 |
Why?
|
| Organ Size | 3 | 2013 | 218 | 0.130 |
Why?
|
| Animals, Newborn | 4 | 2016 | 114 | 0.120 |
Why?
|
| Influenza A virus | 1 | 2014 | 22 | 0.120 |
Why?
|
| Mice, Inbred BALB C | 5 | 2019 | 167 | 0.120 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2014 | 17 | 0.120 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 5 | 2016 | 153 | 0.120 |
Why?
|
| Gene Expression Regulation, Bacterial | 2 | 2011 | 8 | 0.120 |
Why?
|
| Whooping Cough | 2 | 2014 | 11 | 0.120 |
Why?
|
| Viral Vaccines | 2 | 2011 | 11 | 0.120 |
Why?
|
| Virulence Factors, Bordetella | 1 | 2014 | 9 | 0.120 |
Why?
|
| Lactation | 1 | 2014 | 16 | 0.120 |
Why?
|
| Polysaccharides, Bacterial | 1 | 2014 | 10 | 0.120 |
Why?
|
| Milk | 1 | 2014 | 16 | 0.120 |
Why?
|
| Pseudomonas Infections | 2 | 2011 | 14 | 0.120 |
Why?
|
| Complement System Proteins | 1 | 2014 | 9 | 0.120 |
Why?
|
| Vaccination | 1 | 2015 | 138 | 0.110 |
Why?
|
| Ovarian Follicle | 2 | 2010 | 30 | 0.110 |
Why?
|
| Phytosterols | 1 | 2013 | 1 | 0.110 |
Why?
|
| Influenza, Human | 1 | 2014 | 122 | 0.110 |
Why?
|
| Carcinogens | 2 | 2012 | 35 | 0.110 |
Why?
|
| Signal Transduction | 2 | 2008 | 682 | 0.110 |
Why?
|
| Acetylcysteine | 1 | 2012 | 11 | 0.110 |
Why?
|
| Free Radical Scavengers | 1 | 2012 | 14 | 0.110 |
Why?
|
| Inflammation | 1 | 2016 | 530 | 0.110 |
Why?
|
| Cyclohexenes | 2 | 2010 | 13 | 0.110 |
Why?
|
| Vinyl Compounds | 2 | 2010 | 9 | 0.110 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2013 | 60 | 0.110 |
Why?
|
| Bile Acids and Salts | 1 | 2012 | 8 | 0.100 |
Why?
|
| Analysis of Variance | 2 | 2010 | 463 | 0.100 |
Why?
|
| Ovary | 2 | 2010 | 58 | 0.100 |
Why?
|
| Membrane Transport Proteins | 1 | 2012 | 35 | 0.100 |
Why?
|
| Pneumonia, Bacterial | 2 | 2012 | 32 | 0.100 |
Why?
|
| Fibroblast Growth Factors | 1 | 2012 | 35 | 0.100 |
Why?
|
| Humans | 17 | 2019 | 32005 | 0.100 |
Why?
|
| Paramyxovirinae | 1 | 2011 | 2 | 0.100 |
Why?
|
| Phosphorylcholine | 2 | 2009 | 5 | 0.100 |
Why?
|
| Viral Envelope Proteins | 1 | 2011 | 10 | 0.100 |
Why?
|
| Vaccinia | 1 | 2011 | 6 | 0.100 |
Why?
|
| Coronary Vessels | 1 | 2013 | 165 | 0.100 |
Why?
|
| Vaccinia virus | 1 | 2011 | 14 | 0.100 |
Why?
|
| Feeding Behavior | 1 | 2013 | 161 | 0.100 |
Why?
|
| DNA-Binding Proteins | 1 | 2012 | 147 | 0.100 |
Why?
|
| Hydronephrosis | 1 | 2011 | 12 | 0.100 |
Why?
|
| Kidney Medulla | 1 | 2011 | 29 | 0.090 |
Why?
|
| Membrane Glycoproteins | 1 | 2011 | 101 | 0.090 |
Why?
|
| Mice, Knockout | 4 | 2014 | 443 | 0.090 |
Why?
|
| Sexual Development | 1 | 2010 | 3 | 0.090 |
Why?
|
| Autonomic Nervous System | 1 | 2011 | 43 | 0.090 |
Why?
|
| Ovarian Diseases | 1 | 2010 | 8 | 0.090 |
Why?
|
| Heterocyclic Compounds | 1 | 2010 | 12 | 0.090 |
Why?
|
| Feces | 1 | 2010 | 38 | 0.090 |
Why?
|
| Soybean Proteins | 2 | 2008 | 74 | 0.090 |
Why?
|
| Organometallic Compounds | 1 | 2010 | 23 | 0.090 |
Why?
|
| Cross Protection | 1 | 2010 | 1 | 0.090 |
Why?
|
| Electrochemotherapy | 1 | 2010 | 3 | 0.090 |
Why?
|
| Pertussis Vaccine | 1 | 2010 | 2 | 0.090 |
Why?
|
| alpha-Glucosidases | 1 | 2010 | 2 | 0.090 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2011 | 261 | 0.090 |
Why?
|
| Weaning | 1 | 2010 | 6 | 0.090 |
Why?
|
| Hyperphagia | 1 | 2010 | 3 | 0.090 |
Why?
|
| Growth Disorders | 1 | 2010 | 5 | 0.090 |
Why?
|
| Needles | 1 | 2010 | 31 | 0.090 |
Why?
|
| Cardiomyopathies | 1 | 2010 | 56 | 0.090 |
Why?
|
| Heart | 1 | 2011 | 177 | 0.090 |
Why?
|
| Estrogens | 2 | 2008 | 180 | 0.090 |
Why?
|
| Contrast Media | 1 | 2010 | 138 | 0.090 |
Why?
|
| Carbon-Sulfur Lyases | 1 | 2009 | 1 | 0.090 |
Why?
|
| Pseudomonas Vaccines | 1 | 2009 | 1 | 0.080 |
Why?
|
| Nanomedicine | 1 | 2009 | 16 | 0.080 |
Why?
|
| Epitopes | 1 | 2009 | 24 | 0.080 |
Why?
|
| Anticarcinogenic Agents | 1 | 2009 | 25 | 0.080 |
Why?
|
| RNA | 1 | 2010 | 92 | 0.080 |
Why?
|
| Antineoplastic Agents | 2 | 2019 | 608 | 0.080 |
Why?
|
| Bordetella Infections | 1 | 2008 | 1 | 0.080 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 2008 | 7 | 0.080 |
Why?
|
| Immunization, Passive | 1 | 2008 | 9 | 0.080 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2010 | 170 | 0.080 |
Why?
|
| Bacterial Vaccines | 1 | 2008 | 8 | 0.080 |
Why?
|
| Dietary Supplements | 1 | 2010 | 185 | 0.080 |
Why?
|
| Phototherapy | 1 | 2009 | 52 | 0.080 |
Why?
|
| Mucociliary Clearance | 1 | 2008 | 1 | 0.080 |
Why?
|
| Iron Chelating Agents | 1 | 2008 | 7 | 0.080 |
Why?
|
| Food, Formulated | 1 | 2008 | 12 | 0.080 |
Why?
|
| Proteins | 1 | 2010 | 144 | 0.080 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2008 | 41 | 0.080 |
Why?
|
| Iron, Dietary | 1 | 2008 | 13 | 0.080 |
Why?
|
| Rhabdoviridae Infections | 1 | 2008 | 1 | 0.080 |
Why?
|
| Contraceptives, Oral | 1 | 2008 | 23 | 0.080 |
Why?
|
| Viral Matrix Proteins | 1 | 2008 | 9 | 0.080 |
Why?
|
| Pulmonary Emphysema | 1 | 2008 | 21 | 0.080 |
Why?
|
| Vesicular stomatitis Indiana virus | 1 | 2008 | 13 | 0.080 |
Why?
|
| Viral Structural Proteins | 1 | 2008 | 7 | 0.080 |
Why?
|
| Rubulavirus Infections | 1 | 2008 | 7 | 0.080 |
Why?
|
| DNA | 1 | 2010 | 226 | 0.080 |
Why?
|
| Gene Dosage | 1 | 2008 | 35 | 0.080 |
Why?
|
| Immunity, Mucosal | 1 | 2008 | 5 | 0.080 |
Why?
|
| Viral Proteins | 1 | 2008 | 35 | 0.080 |
Why?
|
| Phosphoproteins | 1 | 2008 | 49 | 0.080 |
Why?
|
| Rabbits | 1 | 2008 | 197 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2016 | 1428 | 0.080 |
Why?
|
| Propiophenones | 1 | 2007 | 4 | 0.080 |
Why?
|
| Radiation-Sensitizing Agents | 1 | 2007 | 15 | 0.070 |
Why?
|
| Uterus | 2 | 2006 | 103 | 0.070 |
Why?
|
| Doxycycline | 4 | 2009 | 26 | 0.070 |
Why?
|
| Chinchilla | 3 | 2012 | 3 | 0.070 |
Why?
|
| Cell Line, Tumor | 3 | 2019 | 726 | 0.070 |
Why?
|
| Kidney Neoplasms | 1 | 2009 | 201 | 0.070 |
Why?
|
| Apoptosis | 1 | 2009 | 360 | 0.070 |
Why?
|
| Prenatal Injuries | 1 | 2006 | 3 | 0.070 |
Why?
|
| RNA, Messenger | 3 | 2016 | 508 | 0.070 |
Why?
|
| Virulence | 3 | 2012 | 22 | 0.070 |
Why?
|
| Mice, Nude | 3 | 2016 | 291 | 0.070 |
Why?
|
| ras Proteins | 1 | 2006 | 10 | 0.070 |
Why?
|
| Hyperthermia, Induced | 1 | 2009 | 243 | 0.070 |
Why?
|
| Postmenopause | 2 | 2008 | 430 | 0.070 |
Why?
|
| Ferritins | 1 | 2006 | 47 | 0.070 |
Why?
|
| Mice, Transgenic | 4 | 2009 | 264 | 0.070 |
Why?
|
| Homeostasis | 1 | 2006 | 132 | 0.060 |
Why?
|
| Iron | 1 | 2006 | 116 | 0.060 |
Why?
|
| Antibodies, Bacterial | 3 | 2010 | 32 | 0.060 |
Why?
|
| Colony Count, Microbial | 3 | 2010 | 18 | 0.060 |
Why?
|
| Aging | 2 | 2009 | 946 | 0.060 |
Why?
|
| Stress, Physiological | 2 | 2017 | 55 | 0.060 |
Why?
|
| Cecum | 1 | 2004 | 8 | 0.060 |
Why?
|
| Soybeans | 1 | 2004 | 35 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2010 | 1328 | 0.060 |
Why?
|
| Estrogens, Conjugated (USP) | 1 | 2004 | 140 | 0.060 |
Why?
|
| Radiography | 1 | 2004 | 376 | 0.050 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2006 | 1062 | 0.050 |
Why?
|
| Injections, Intraperitoneal | 2 | 2013 | 45 | 0.050 |
Why?
|
| Immunity, Innate | 2 | 2014 | 75 | 0.050 |
Why?
|
| Myocardium | 2 | 2013 | 186 | 0.050 |
Why?
|
| Spleen | 2 | 2013 | 87 | 0.050 |
Why?
|
| Neutralization Tests | 2 | 2011 | 12 | 0.040 |
Why?
|
| Prosthesis Implantation | 1 | 2019 | 40 | 0.040 |
Why?
|
| Lanthanoid Series Elements | 1 | 2019 | 2 | 0.040 |
Why?
|
| Bioengineering | 1 | 2019 | 70 | 0.040 |
Why?
|
| Alpha Particles | 1 | 2019 | 7 | 0.040 |
Why?
|
| Chelating Agents | 1 | 2019 | 17 | 0.040 |
Why?
|
| Maximum Tolerated Dose | 1 | 2019 | 62 | 0.040 |
Why?
|
| Mice, SCID | 1 | 2019 | 71 | 0.040 |
Why?
|
| Neoplasm Transplantation | 1 | 2019 | 73 | 0.040 |
Why?
|
| Radiometry | 1 | 2019 | 40 | 0.040 |
Why?
|
| Swine | 1 | 2019 | 215 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2010 | 115 | 0.040 |
Why?
|
| Gold | 1 | 2018 | 18 | 0.040 |
Why?
|
| Neoplasm Metastasis | 1 | 2019 | 220 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2008 | 263 | 0.040 |
Why?
|
| Polymers | 1 | 2018 | 64 | 0.040 |
Why?
|
| Liver | 2 | 2013 | 484 | 0.040 |
Why?
|
| Organ Specificity | 2 | 2009 | 81 | 0.040 |
Why?
|
| Nanoparticles | 1 | 2018 | 52 | 0.040 |
Why?
|
| Ceruloplasmin | 1 | 2017 | 5 | 0.040 |
Why?
|
| Ions | 1 | 2017 | 12 | 0.040 |
Why?
|
| Enzyme Activation | 1 | 2017 | 135 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2009 | 633 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 2008 | 538 | 0.030 |
Why?
|
| Toll-Like Receptor 8 | 1 | 2016 | 5 | 0.030 |
Why?
|
| Primates | 1 | 2017 | 108 | 0.030 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2016 | 9 | 0.030 |
Why?
|
| Integrin alphaVbeta3 | 1 | 2016 | 7 | 0.030 |
Why?
|
| Microglia | 1 | 2016 | 57 | 0.030 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2016 | 47 | 0.030 |
Why?
|
| Phenotype | 2 | 2008 | 632 | 0.030 |
Why?
|
| Antibody Formation | 1 | 2014 | 46 | 0.030 |
Why?
|
| Prognosis | 1 | 2019 | 1497 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2015 | 124 | 0.030 |
Why?
|
| Complement Membrane Attack Complex | 1 | 2014 | 1 | 0.030 |
Why?
|
| Time Factors | 2 | 2010 | 2149 | 0.030 |
Why?
|
| Hepatomegaly | 1 | 2013 | 2 | 0.030 |
Why?
|
| Splenomegaly | 1 | 2013 | 7 | 0.030 |
Why?
|
| Muscle, Skeletal | 2 | 2009 | 519 | 0.030 |
Why?
|
| Mice, Inbred A | 1 | 2012 | 4 | 0.030 |
Why?
|
| Nitrosamines | 1 | 2012 | 11 | 0.030 |
Why?
|
| Erythrocytes | 1 | 2013 | 48 | 0.030 |
Why?
|
| Genetic Complementation Test | 1 | 2012 | 3 | 0.030 |
Why?
|
| Cholesterol 7-alpha-Hydroxylase | 1 | 2012 | 2 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2014 | 671 | 0.030 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2012 | 12 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2013 | 276 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2012 | 67 | 0.030 |
Why?
|
| Intestine, Small | 1 | 2012 | 40 | 0.030 |
Why?
|
| Weight Gain | 1 | 2013 | 117 | 0.030 |
Why?
|
| Whole Body Imaging | 1 | 2011 | 6 | 0.020 |
Why?
|
| Antibodies, Neutralizing | 1 | 2011 | 19 | 0.020 |
Why?
|
| Antigens, Viral | 1 | 2011 | 21 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2011 | 58 | 0.020 |
Why?
|
| Disease Susceptibility | 1 | 2011 | 57 | 0.020 |
Why?
|
| Rodent Diseases | 1 | 2011 | 1 | 0.020 |
Why?
|
| von Willebrand Factor | 1 | 2011 | 16 | 0.020 |
Why?
|
| Platelet Activation | 1 | 2011 | 13 | 0.020 |
Why?
|
| Platelet Count | 1 | 2011 | 23 | 0.020 |
Why?
|
| Quorum Sensing | 1 | 2011 | 2 | 0.020 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2011 | 18 | 0.020 |
Why?
|
| Cyclic GMP | 1 | 2011 | 13 | 0.020 |
Why?
|
| Infant | 1 | 2014 | 1061 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2018 | 765 | 0.020 |
Why?
|
| Anti-Mullerian Hormone | 1 | 2010 | 15 | 0.020 |
Why?
|
| Thrombosis | 1 | 2011 | 73 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2011 | 91 | 0.020 |
Why?
|
| Gadolinium | 1 | 2010 | 22 | 0.020 |
Why?
|
| Cholesterol | 1 | 2012 | 252 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2012 | 231 | 0.020 |
Why?
|
| Baroreflex | 1 | 2011 | 84 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2010 | 62 | 0.020 |
Why?
|
| Opsonin Proteins | 1 | 2010 | 4 | 0.020 |
Why?
|
| Vaccines, Attenuated | 1 | 2010 | 11 | 0.020 |
Why?
|
| Diet | 1 | 2013 | 391 | 0.020 |
Why?
|
| Phagocytosis | 1 | 2010 | 14 | 0.020 |
Why?
|
| Respiratory System | 1 | 2010 | 11 | 0.020 |
Why?
|
| Electrodes | 1 | 2010 | 17 | 0.020 |
Why?
|
| Histocytochemistry | 1 | 2010 | 31 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2013 | 495 | 0.020 |
Why?
|
| Microscopy | 1 | 2010 | 26 | 0.020 |
Why?
|
| Homoserine | 1 | 2009 | 1 | 0.020 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2009 | 7 | 0.020 |
Why?
|
| Infrared Rays | 1 | 2009 | 18 | 0.020 |
Why?
|
| Angiotensin II | 1 | 2011 | 244 | 0.020 |
Why?
|
| Lactones | 1 | 2009 | 10 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2011 | 406 | 0.020 |
Why?
|
| Renin-Angiotensin System | 1 | 2011 | 179 | 0.020 |
Why?
|
| Butylated Hydroxytoluene | 1 | 2009 | 1 | 0.020 |
Why?
|
| Sulindac | 1 | 2009 | 1 | 0.020 |
Why?
|
| Temperature | 1 | 2009 | 55 | 0.020 |
Why?
|
| Complement C3 | 1 | 2009 | 9 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 2009 | 34 | 0.020 |
Why?
|
| Myositis | 1 | 2009 | 10 | 0.020 |
Why?
|
| Injections, Intramuscular | 1 | 2009 | 43 | 0.020 |
Why?
|
| Sexual Maturation | 1 | 2009 | 25 | 0.020 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2008 | 17 | 0.020 |
Why?
|
| Heart Rate | 1 | 2011 | 335 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 2008 | 25 | 0.020 |
Why?
|
| Hematocrit | 1 | 2008 | 23 | 0.020 |
Why?
|
| Catheter Ablation | 1 | 2009 | 67 | 0.020 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2008 | 14 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2009 | 105 | 0.020 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2008 | 33 | 0.020 |
Why?
|
| Hemoglobins | 1 | 2008 | 49 | 0.020 |
Why?
|
| Transferrin | 1 | 2008 | 33 | 0.020 |
Why?
|
| Nasal Mucosa | 1 | 2008 | 18 | 0.020 |
Why?
|
| Ventricular Function, Left | 1 | 2010 | 245 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2008 | 94 | 0.020 |
Why?
|
| Nose | 1 | 2008 | 12 | 0.020 |
Why?
|
| Ferrets | 1 | 2008 | 20 | 0.020 |
Why?
|
| Interferons | 1 | 2008 | 17 | 0.020 |
Why?
|
| Point Mutation | 1 | 2008 | 28 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2009 | 157 | 0.020 |
Why?
|
| Transgenes | 1 | 2008 | 48 | 0.020 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2008 | 14 | 0.020 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2008 | 16 | 0.020 |
Why?
|
| Central Nervous System | 1 | 2008 | 43 | 0.020 |
Why?
|
| Administration, Intranasal | 1 | 2008 | 31 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2016 | 3306 | 0.020 |
Why?
|
| Random Allocation | 1 | 2008 | 226 | 0.020 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2008 | 40 | 0.020 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2008 | 59 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2008 | 120 | 0.020 |
Why?
|
| HT29 Cells | 1 | 2007 | 4 | 0.020 |
Why?
|
| Embryo, Nonmammalian | 1 | 2007 | 4 | 0.020 |
Why?
|
| Combinatorial Chemistry Techniques | 1 | 2007 | 4 | 0.020 |
Why?
|
| RNA-Binding Proteins | 1 | 2008 | 68 | 0.020 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2007 | 17 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2010 | 876 | 0.020 |
Why?
|
| Smoking | 1 | 2011 | 497 | 0.020 |
Why?
|
| Zebrafish | 1 | 2007 | 23 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2008 | 111 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2008 | 187 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2008 | 247 | 0.020 |
Why?
|
| Linear Models | 1 | 2008 | 447 | 0.020 |
Why?
|
| DNA Repair | 1 | 2007 | 64 | 0.020 |
Why?
|
| Stroke Volume | 1 | 2010 | 348 | 0.020 |
Why?
|
| Endometrium | 1 | 2008 | 180 | 0.020 |
Why?
|
| Body Weight | 1 | 2009 | 310 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2008 | 210 | 0.020 |
Why?
|
| Methylcholanthrene | 1 | 2006 | 6 | 0.020 |
Why?
|
| Inbreeding | 1 | 2006 | 5 | 0.020 |
Why?
|
| Retinoblastoma Protein | 1 | 2006 | 10 | 0.020 |
Why?
|
| Cyclin D1 | 1 | 2006 | 14 | 0.020 |
Why?
|
| Fetal Development | 1 | 2006 | 26 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2011 | 845 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2006 | 22 | 0.020 |
Why?
|
| DNA Primers | 1 | 2006 | 91 | 0.020 |
Why?
|
| Hela Cells | 1 | 2006 | 79 | 0.020 |
Why?
|
| Cytomegalovirus | 1 | 2006 | 31 | 0.020 |
Why?
|
| DNA, Neoplasm | 1 | 2006 | 55 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2006 | 77 | 0.020 |
Why?
|
| Glioma | 1 | 2007 | 136 | 0.020 |
Why?
|
| Fetus | 1 | 2006 | 86 | 0.020 |
Why?
|
| Base Sequence | 1 | 2006 | 252 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2008 | 833 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2007 | 560 | 0.020 |
Why?
|
| ral GTP-Binding Proteins | 1 | 2005 | 2 | 0.020 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2005 | 6 | 0.020 |
Why?
|
| Pulmonary Alveoli | 1 | 2005 | 19 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2005 | 36 | 0.020 |
Why?
|
| Hyperplasia | 1 | 2005 | 41 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2005 | 43 | 0.020 |
Why?
|
| Bronchi | 1 | 2005 | 33 | 0.020 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2005 | 36 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2008 | 324 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2005 | 73 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2005 | 170 | 0.020 |
Why?
|
| Protein-Serine-Threonine Kinases | 1 | 2005 | 50 | 0.020 |
Why?
|
| Colorectal Neoplasms | 1 | 2007 | 215 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2006 | 181 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2005 | 229 | 0.020 |
Why?
|
| Alleles | 1 | 2005 | 248 | 0.020 |
Why?
|
| Gene Expression | 1 | 2006 | 338 | 0.020 |
Why?
|
| Receptors, Steroid | 1 | 2004 | 9 | 0.020 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2004 | 34 | 0.010 |
Why?
|
| Ovariectomy | 1 | 2004 | 166 | 0.010 |
Why?
|
| Kidney | 1 | 2006 | 518 | 0.010 |
Why?
|
| Brain | 1 | 2008 | 951 | 0.010 |
Why?
|